Patent 11304959 was granted and assigned to TherapeuticsMD on April, 2022 by the United States Patent and Trademark Office.
According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.